Inotuzumab Ozogamicin – March 2026

Powder for I.V. infusion 1 mg

  • Brand names:
    • Besponsa®
  • Pharmaceutical Company:
    • PFIZER AUSTRALIA PTY LTD
  • Condition/Indication: Acute lymphoblastic leukaemia (ALL)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026